Orolingual angiooedema secondary to alteplase treatment in cases of stroke;Angioedema orolingual secundario al tratamiento con alteplasa en el ictus

Revista de Neurologia

Volumn 46, Issue 6, 2008, Pages 382-

  Giménez Muñoz, Álvaro ^a   Capablo Liesa, J L ^a   Torne Hernandez L ^a   Sagarra Mur, D ^a   Sebastian Torres B ^a   Alarcia Alejos, R ^a  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALTEPLASE;

ADULT; ANGIONEUROTIC EDEMA; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; MEDICAL EXAMINATION; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; STROKE;

EID: 41849142281     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4606.2008110     Document Type: Letter

References (11)

1. Purvis JA, Booth NA, Wilson CM, Aggi JAA, McClusky DR. Anaphylactoid reaction after injection of alteplase. Lancet 1993; 341: 966-7.
2. Massell D, Gill JB, Cairns JA. Anaphylactoid reaction during infusion of recombinant tissue-type plasminogen activator for acute myocardial infarction. Can J Cardiol 1991; 7: 298-302.
3. Rudolf J, Grond M, Schmulling S, Neveling M, Heiss W. Orolingual angioneurotic edema following therapy of acute ischemic stroke with alteplase. Neurology 2000; 55: 599-600.
4. Hill MD, Lye T, Moss H, Barber PA, Demchuk AM, Newcommon NJ, et al. Hemiorolingual angioedema and ACE inhibition after alteplase treatment of stroke. Neurology 2003; 60: 1525-7.
5. Engelter ST, Fluri F, Buitrago-Téllez C, Marsch S, Steck AJ, Rüegg S, et al. Orolingual angioedema during thrombolysis in acute ischemic stroke. J Neurol 2005; 252: 1167-70.
6. Rudolf J, Grond M, Prince WS, Schmulling S, Heiss WD. Evidence of anaphylaxy following alteplase infusion. Stroke 1999; 30: 1142-3.
7. Reed BR, Chen AB, Tanswell P, Prince WS, Wert RM Jr, Glaesle-Schwarz L, et al. Low incidence of antibodies to recombinant human tissue-type plasminogen activator in treated patients. Thromb Haemost 1990; 64: 276-80.
8. Molinaro G, Gervais N, Adam A. Biochemical basis of angioedema associated with recombinant tissue plasminogen activator treatment: an in vitro experimental approach. Stroke 2002; 33: 1712-6.
9. Blais C Jr, Rouleau JL, Brown NJ, Lepage Y, Spence D, Muñoz C, et al. Serum metabolism of bradykinin and des-Arg9-bradykinin in patients with angiotensin-converting enzyme inhibitor-associated angioedema. Immunopharmacology 1999; 43: 293-302.
10. Hill MD, Barber PA, Tahakashi J, Demchuck AM, Feasby TE, Buchan AM. Anaphylactoid reactions and angioedema during alteplase treatment of acute ischemic stroke. CMAJ 2000; 162: 1281-4.
11. Rafii MS, Koenig M, Ziai WC. Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke. Neurology 2005; 65: 1906.